financetom
Business
financetom
/
Business
/
JSR's incoming CEO signals focus on finances, retreat from sector M&A ambitions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JSR's incoming CEO signals focus on finances, retreat from sector M&A ambitions
Mar 26, 2025 6:57 PM

TOKYO (Reuters) - The incoming CEO of Japanese chip materials maker JSR plans to focus on restoring the company's business performance, shifting away from previous ambitions to drive consolidation in the sector.

JSR's financial performance is not good, and the company is not ready to make acquisitions, Tetsuro Hori, who will assume the CEO role on April 1, said in an interview on Wednesday.

"We need to recover the life science business. This is the first priority," he said.

The company's business performance has deteriorated, affected by losses in its life sciences unit, sparking industry speculation that JSR may attempt to sell the division.

"JSR might not be the best owner of the life science (business), that's what I'm thinking right now," said Hori, adding that nothing has been decided and the business' performance would need to improve before any potential sale.

Under outgoing CEO Eric Johnson, JSR was taken private by the state-backed Japan Investment Corp (JIC) last year in a $6 billion deal.

Johnson had argued that the buyout would free JSR, a leading maker of photoresists for chipmaking, from the challenge of managing its foreign investor base, enabling the company to pursue sector deals.

However, the transaction has been controversial, with some in the industry questioning whether JSR could successfully make deals that would significantly reshape the sector.

Hori said that M&A must be supported by customers, and they must also create value.

Hori joined JSR as chief financial officer in January, and had previously served as an executive at chipmaking equipment manufacturer Tokyo Electron ( TOELF ).

Hidehito Takahashi, the CEO of chip materials maker Resonac ( SHWDF ), said last month that he would like his company to be involved when JIC exits JSR.

"If we can find some good synergy probably those deals could be on the table," Hori said, adding that he hasn't had discussions with Resonac ( SHWDF ).

JSR booked a net loss of 22.2 billion yen ($148 million) in the six-month period ended September 30.

Hori hopes to return the business to profitability by the next financial year, which ends in March 2026.

($1 = 150.3800 yen)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RTX Insider Sold Shares Worth $3,569,135, According to a Recent SEC Filing
RTX Insider Sold Shares Worth $3,569,135, According to a Recent SEC Filing
Mar 4, 2025
02:52 AM EST, 03/04/2025 (MT Newswires) -- Christopher T. Calio, Director, President and Chief Executive Officer, on February 27, 2025, sold 27,379 shares in RTX (RTX) for $3,569,135. Following the Form 4 filing with the SEC, Calio has control over a total of 85,781 common shares of the company, with 81,508 shares held directly and 4,273 controlled indirectly. SEC Filing:...
Skechers USA Insider Sold Shares Worth $2,044,939, According to a Recent SEC Filing
Skechers USA Insider Sold Shares Worth $2,044,939, According to a Recent SEC Filing
Mar 3, 2025
02:39 AM EST, 03/04/2025 (MT Newswires) -- Michael Greenberg, Director, President, on March 01, 2025, sold 33,656 shares in Skechers USA ( SKX ) for $2,044,939. Following the Form 4 filing with the SEC, Greenberg has control over a total of 137,530 Class A common shares of the company, with 137,530 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1065837/000095017025031217/xslF345X05/ownership.xml ...
Intuitive Surgical Insider Sold Shares Worth $1,749,783, According to a Recent SEC Filing
Intuitive Surgical Insider Sold Shares Worth $1,749,783, According to a Recent SEC Filing
Mar 4, 2025
02:48 AM EST, 03/04/2025 (MT Newswires) -- Myriam Curet, Executive Vice President & Chief Medical Officer, on February 27, 2025, sold 3,031 shares in Intuitive Surgical ( ISRG ) for $1,749,783. Following the Form 4 filing with the SEC, Curet has control over a total of 353 common shares of the company, with 353 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000076/xslF345X05/edgardoc.xml...
Workday Insider Sold Shares Worth $1,607,858, According to a Recent SEC Filing
Workday Insider Sold Shares Worth $1,607,858, According to a Recent SEC Filing
Mar 4, 2025
02:45 AM EST, 03/04/2025 (MT Newswires) -- Sayan Chakraborty, President, Product and Technology, on February 27, 2025, sold 6,056 shares in Workday (WDAY) for $1,607,858. Following the Form 4 filing with the SEC, Chakraborty has control over a total of 121,040 Class A common shares of the company, with 111,324 shares held directly and 9,716 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1327811/000132781125000043/xslF345X05/wk-form4_1741048343.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved